Prevalence and Incidence of Osteogenesis imperfecta congenita, microcephaly, and cataracts

Osteogenesis imperfecta congenita, microcephaly, and cataracts: Rare Disease

Osteogenesis imperfecta congenita, microcephaly, and cataracts is listed as a "rare disease" by the Office of Rare Diseases (ORD) of the National Institutes of Health (NIH). This means that Osteogenesis imperfecta congenita, microcephaly, and cataracts, or a subtype of Osteogenesis imperfecta congenita, microcephaly, and cataracts, affects less than 200,000 people in the US population.

Ophanet, who are a consortium of European partners, currently defines a condition rare when if affects 1 person per 2,000. They list Osteogenesis imperfecta congenita, microcephaly, and cataracts as a "rare disease". More information about Osteogenesis imperfecta congenita, microcephaly, and cataracts is available from Orphanet

About prevalence and incidence statistics:

The term 'prevalence' of Osteogenesis imperfecta congenita, microcephaly, and cataracts usually refers to the estimated population of people who are managing Osteogenesis imperfecta congenita, microcephaly, and cataracts at any given time. The term 'incidence' of Osteogenesis imperfecta congenita, microcephaly, and cataracts refers to the annual diagnosis rate, or the number of new cases of Osteogenesis imperfecta congenita, microcephaly, and cataracts diagnosed each year. Hence, these two statistics types can differ: a short-lived disease like flu can have high annual incidence but low prevalence, but a life-long disease like diabetes has a low annual incidence but high prevalence. For more information see about prevalence and incidence statistics.

Search Specialists by State and City